Nervous System Diseases
188
43
51
85
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
28 trials with published results (15%)
Research Maturity
85 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.4%
14 terminated out of 188 trials
85.9%
-0.7% vs benchmark
13%
25 trials in Phase 3/4
33%
28 of 85 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 85 completed trials
Clinical Trials (188)
Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Shoulder Health After Rehabilitation and Performance Training
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
Domain-Specific Large Language Model Assistance for Emergency Neurological Diagnosis and Treatment（DEMAND）
Rett Syndrome Registry
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Impact of Transcutaneous Spinal Stimulation on Blood Pressure and Orthostasis in Spinal Cord Injury
Neurologic Stem Cell Treatment Study
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Brain Connections for Arm Movement After Stroke
Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial
Video Call Assisted Assessment of Acute Stroke
Comprehensive Management of High-risk PopuLatIon for Stroke Based on Social Network
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin
Functional Near-infrared Spectroscopy in Unconscious Patients